TokenPost·
Tarsus Pharmaceuticals Revenue Climbs 63.9% to $194.5 Million in Q3
GAAP earnings per share was -$14.40. Cash, cash equivalents and marketable securities totaled $309.6 million as of Sept. 30.
More news
- TokenPostBlock's Proposed Three-Year DOJ Agreement Carries an Expected $764 Million Net Payment
- Crypto BriefingDruckenmiller invests in TradeXYZ to bring Hyperliquid futures to US investors
- Crypto BriefingAnthropic expands IPO to Australia, Japan, Canada, UK amid $1.5T-$2T valuation aim
- crypto.newsCFTC faces lawsuit after allowing perpetual futures trading on U.S. stocks
- CryptonewsCopilot AI Predicts an Explosive Q4 Move for NEAR Protocol
- NewsBTCSEC Updates Crypto-Asset FAQs as Firms Seek Clarity on Federal Securities Rules